25 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Ji, Hematology / Oncology Specialist in Palo Alto, CA?
Dr. Hanlee Ji, MD is a Hematology / Oncology Specialist, who primarily practices in Palo Alto, CA with 1 additional practice location. He has been practicing for over 25 years and is board certified by the American Board of Internal Medicine. Dr. Ji completed his residency at University Of Iowa Hospitals and Clinics. Dr. Ji is fluent in English, and is currently seeing new patients. Dr. Ji’s practice accepts Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Ji’s office at (650) 498-6000.
Where did Dr. Ji go to medical school and complete their residency?
Residency: University Of Iowa Hospitals and Clinics
Is Dr. Ji board certified in Hematology / Oncology Specialist?
Yes, Dr. Hanlee Ji, MD is board certified by the American Board of Internal Medicine since 2004
What languages does Dr. Ji speak?
Dr. Ji and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Ji treat?
As a Hematology / Oncology Specialist, Dr. Ji diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Ji. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Colorectal Cancer
- Colon cancer
- Rectal cancer
- Bowel cancer
- Malignant neoplasm of colon
ICD-10 Codes:
- C189: Malignant neoplasm of colon, unspecified
Which procedures does Dr. Ji perform as a Hematology / Oncology Specialist?
As a Hematology / Oncology Specialist, procedures performed by a Dr. Hanlee Ji may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Ji's office.
Does Dr. Ji accept my insurance?
Dr. Ji accepts most major insurance plans. Important: Please call our office at (650) 498-6000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Ji accept in Palo Alto, CA?
Dr. Ji in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Central California Alliance for Health
Department of Veterans Affairs
Imperial Health Plan (CA)
Managed Care of America
Medicare
Partnership Health Plan
Santa Clara Family Health Plan
Valley Health Plan
View All Insurances
Where is Dr. Ji's office located?
Recognitions
Publications
High sensitivity detection and quantitation of D copy number and single nucleotide variants with
Alytical chemistry, 2014
Identification of Insertion Deletion Mutations from Deep Targeted Resequencing.
Jourl of data mining in genomics & proteomics, 2013
DETECTING MUTATIONS IN MIXED SAMPLE SEQUENCING DATA USING EMPIRICAL BAYES
ANLS OF APPLIED STATISTICS, 2012
Performance comparison of whole-genome sequencing platforms
TURE BIOTECHNOLOGY, 2012
Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin
Translatiol medicine (Sunnyvale, Calif.), 2012
Targeted sequencing library preparation by genomic D circularization
BMC BIOTECHNOLOGY, 2011
Efficient targeted resequencing of human germline
TURE BIOTECHNOLOGY, 2011
Genetic-based biomarkers and next-generation sequencing
PERSOLIZED MEDICINE, 2011
Oncogenic BRAF Mutation with CDKN2A Ictivation Is Characteristic of a Subset of Pediatric Malignt
CANCER RESEARCH, 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURL OF TRANSLATIOL MEDICINE, 2009
Next-generation D sequencing
TURE BIOTECHNOLOGY, 2008
Multigene amplification and massively parallel sequencing for cancer mutation discovery
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2007
Multiplexed protein detection by proximity ligation for cancer biomarker validation
TURE METHODS, 2007
Under-expression of Kalirin-7 increases iNOS activity in cultured cells
JOURL OF ALZHEIMERS DISEASE, 2007
Reproducibility Probability Score
TURE BIOTECHNOLOGY, 2006
The MicroArray Quality Control
TURE BIOTECHNOLOGY, 2006
Data quality in genomics and microarrays
TURE BIOTECHNOLOGY, 2006
Molecular inversion probe alysis of gene copy alterations reveals distinct categories of colorectal
CANCER RESEARCH, 2006
A functiol assay for mutations in tumor suppressor genes caused by mismatch repair deficiency
HUMAN MOLECULAR GENETICS, 2001
Spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL)
AMERICAN JOURL OF MEDICAL GENETICS, 1999
Molecular classification of the inherited hamartoma polyposis syndromes
AMERICAN JOURL OF HUMAN GENETICS, 1998
Inherited mutations in PTEN that are associated with breast cancer, Cowden disease
AMERICAN JOURL OF HUMAN GENETICS, 1997
HOTSPOTS FOR UNSELECTED TY1 TRANSPOSITION EVENTS ON YEAST CHROMOSOME-III ARE NEAR TRANSFER
CELL, 1993
A programmable method for massively parallel targeted sequencing.
Nucleic acids research, 2014
High sensitivity detection and quantitation of DNA copy number and single nucleotide variants
Analytical chemistry, 2014
Systematic genomic identification of colorectal cancer genes delineating advanced from early
BMC MEDICAL GENOMICS, 2013
RVD: a command-line program for ultrasensitive rare single nucleotide variant detection using
BMC research notes, 2013
Identification of Insertion Deletion Mutations from Deep Targeted Resequencing.
Journal of data mining in genomics & proteomics, 2013
DETECTING MUTATIONS IN MIXED SAMPLE SEQUENCING DATA USING EMPIRICAL BAYES
ANNALS OF APPLIED STATISTICS, 2012
Improving bioinformatic pipelines for exome variant calling
GENOME MEDICINE, 2012
Performance comparison of whole-genome sequencing platforms
NATURE BIOTECHNOLOGY, 2012
A cross-sample statistical model for SNP detection in short-read sequencing data
NUCLEIC ACIDS RESEARCH, 2012
Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin
Translational medicine (Sunnyvale, Calif.), 2012
Identification of a novel deletion mutant strain in Saccharomyces cerevisiae that results in a
BioDiscovery
Ultrasensitive detection of rare mutations using next-generation targeted resequencing
NUCLEIC ACIDS RESEARCH, 2012
The Human OligoGenome Resource
Nucleic acids research, 2012
Targeted sequencing library preparation by genomic DNA circularization
BMC BIOTECHNOLOGY, 2011
Efficient targeted resequencing of human germline
NATURE BIOTECHNOLOGY, 2011
A Flexible Approach for Highly Multiplexed Candidate Gene Targeted Resequencing
PLOS ONE, 2011
Genetic-based biomarkers and next-generation sequencing
PERSONALIZED MEDICINE, 2011
Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric
CANCER RESEARCH, 2010
Detecting simultaneous changepoints in multiple sequences.
Biometrika, 2010
Targeted deep resequencing of the human cancer genome using next-generation technologies
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 27, 2010
Identification of a biomarker panel using a multiplex proximity ligation
JOURNAL OF TRANSLATIONAL MEDICINE, 2009
Molecular inversion probes reveal patterns of 9p21 deletion
CANCER GENETICS AND CYTOGENETICS, 2009
Disperse-a software system for design of selector probes for exon resequencing applications
BIOINFORMATICS, 2009
Molecular inversion probe assay for allelic quantitation.
Methods in molecular biology (Clifton, N.J.), 2009
Next-generation DNA sequencing
NATURE BIOTECHNOLOGY, 2008
Multigene amplification and massively parallel sequencing for cancer mutation discovery
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2007
Multiplex amplification of all coding sequences within 10 cancer genes by Gene-Collector
NUCLEIC ACIDS RESEARCH, 2007
Multiplexed protein detection by proximity ligation for cancer biomarker validation
NATURE METHODS, 2007
Under-expression of Kalirin-7 increases iNOS activity in cultured cells
JOURNAL OF ALZHEIMERS DISEASE, 2007
Reproducibility Probability Score
NATURE BIOTECHNOLOGY, 2006
The MicroArray Quality Control
NATURE BIOTECHNOLOGY, 2006
Data quality in genomics and microarrays
NATURE BIOTECHNOLOGY, 2006
Molecular inversion probe analysis of gene copy alterations reveals distinct categories of
CANCER RESEARCH, 2006
A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency
HUMAN MOLECULAR GENETICS, 2001
Spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL)
AMERICAN JOURNAL OF MEDICAL GENETICS, 1999
Molecular classification of the inherited hamartoma polyposis syndromes
AMERICAN JOURNAL OF HUMAN GENETICS, 1998
Inherited mutations in PTEN that are associated with breast cancer, Cowden disease
AMERICAN JOURNAL OF HUMAN GENETICS, 1997
HOTSPOTS FOR UNSELECTED TY1 TRANSPOSITION EVENTS ON YEAST CHROMOSOME-III ARE NEAR TRANSFER
CELL, 1993
What is Dr. Ji's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Ji's National Provider Identifier (NPI) number is 1639371719.
What common questions do patients ask about Dr. Ji?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Ji
What is Dr. Hanlee Ji's specialty?
Dr. Ji is a Hematology / Oncology Specialist near Palo Alto, CA. An internist doctor of osteopathy specializing in the combined treatment of hematology and oncology disorders. A doctor of osteopathy who is board eligible or certified by the American Osteopathic Board of Internal Medicine was previously able to obtain a Certificate of Special Qualifications in Hematology and Oncology; however, this certificate is no longer available. Contact Dr. Ji to book an appointment today.
Is this Dr. Hanlee Ji affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Ji is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Hematology / Oncology Specialist?
Explore Hematology / Oncology Specialist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Hanlee Ji accepting new patients in Palo Alto, CA?
Yes, Dr. Hanlee Ji is accepting new patients at this time.
Does Dr. Hanlee Ji offer online booking?
Please contact Dr. Ji's office at (650) 498-6000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Hanlee Ji?
Please contact Dr. Ji's office at (650) 498-6000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Hanlee Ji have?
Dr. Hanlee Ji is certified by the American Board of Internal Medicine.
Other Hematology / Oncology Specialist Near Palo Alto, CA
Hematology / Oncology Specialist
Accepting patientsHematology / Oncology Specialist
Accepting patients
Medical Oncologist
Accepting patients